Menu ×


Cardiac Output Monitoring Devices Market Analysis by Product (Consumables & Accessories, and Devices); by Type (Invasive, and Non- invasive); by Technology (Pulmonary Artery Catheter, Lithium Dilution Technique, Thermodilution Pulse Contour Analysis Technique, Arterial Waveform Analysis Technique, Doppler, and Others); and by End-User (Hospitals, Ambulatory Surgical Centers, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • 2022: ICU Medical Inc., completed the acquisition of Smiths Medical from Smiths Group Plc. In addition to syringes and ambulatory infusion devices, Smith Medical also produces vascular access products and vital care products.
  • Schwarzer Cardiotek GmbH, received 510(k) clearance from the US Food and Drug Administration for version 2.2 of its EP-TRACER electronic physiological measurement system, designed to provide high-quality display of intracardiac ECG signals.

Global Cardiac Output Monitoring Devices Market Size, Forecast, and Trend Highlights Over 2022 - 2031


The global cardiac output monitoring devices market is estimated to garner a notable revenue by the end of 2031 by growing at a CAGR of ~6% over the forecast period, i.e., 2022 – 2031. Further, the market generated a revenue of ~USD 1 Billion in the year 2021. The growth of the market is primarily attributed to the worldwide surging occurrences of cardiovascular diseases. As per the data released by the World Health Organization (WHO), 17.9 million people worldwide die from CVDs each year, contributing for 32% of all mortalities.


Get more information on this report: Request Sample PDF

Cardiac output is the amount of blood pumped per minute by the right or left ventricle of the heart which is calculated by the heart rate and stroke volume. This procedure is usually done by electrocardiography, through which the patient's condition is assessed in relation to the heartbeat. As the prevalence of cardiac arrests, respiratory problems, various types of severe infections, and CVDs have been growing, and the count of patients admitted in critical care units for intensive or invasive monitoring have been increasing, therefore, the cardiac output monitoring devices have become a vital element of assessing patients in the operating room, critical care unit, and other places. For instance, in China, 5% of patients died while 28% required admission to the intensive care unit by the end of 2019.

Global Cardiac Output Monitoring Devices Market: Growth Drivers and Challenges

Growth Drivers

  • Increasing Geriatric Population – Globally increasing geriatric population is leading the cause of severe health issues that require the intensive care and monitoring too. According to the World Health Organization (WHO) data, by 2030, globally, the number of people over the age of 60 is estimated to reach 1.4 billion.
  • Rising Prevalence of Chronic Obstructive Pulmonary Disease (COPD)- Chronic obstructive pulmonary disease (COPD) is a long-term chronic condition of lungs that makes it hard for a person to breathe. It is a leading cause of death and disability. For instance, very year, more than 3 million people lose their lives from COPD, which denotes 6% of total deaths globally.
  • Upsurge in Surgical Procedures - Surgery is the only treatment that is capable to relieve disabilities and lower the risk of death from traumatic injuries, cancers and cardiovascular diseases. For instance, every year, approximately 312 million major surgeries are conducted worldwide.
  • Rise in Traumatic Injuries – Many times, incidences such as road accidents, drowning, burn and violence result in severe traumatic injury to the people and prove life threatening. For instance, each year, around 4.4 million people worldwide lose their lives to injuries, both intentional and owing to violence, which accounts for close to 8% of all mortalities.
  • Escalating Healthcare Expenditure – According to the data released by the World Bank, the worldwide healthcare expenditure was grown to 9.83% in 2019 as compared to 9.7% in 2018.


  • High Costs of Cardiac Output Monitoring Devices
  • Preference for Medicines Over Surgery
  • Limited Insurance Coverage Options

The global cardiac output monitoring devices market is segmented and analyzed for demand and supply by end-user into hospitals, ambulatory surgical centers, and others, out of which, the hospitals segment is anticipated to significantly grow over the forecast period owing to the escalating number of patients visits to be diagnosed in hospitals, rising incidences of CVDs, availability of medical reimbursement, and the increasing count of cardiac implant surgeries. According to the data provided by the National Center of Biotechnology and Information, every year, nearly 400,000 coronary artery bypass grafting (CABG) surgeries are performed.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Cardiac Output Monitoring Devices Market Regional Synopsis

Regionally, the global cardiac output monitoring devices market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2031 backed by the rise in healthcare expenditure, growing cases of CVDs, increasing disposable income, and accessibility of technologically advanced equipment in the region. As per the data provided by the Centers for disease Control and Prevention, in the United States, heart disease accounted for the deaths of about 697,000 people in 2020. Furthermore, coronary artery disease affects nearly 20.1 million adults aged 20 and up.


The global cardiac output monitoring devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global cardiac output monitoring devices market includes the following segments:

By Product

  • Consumables & Accessories
  • Devices

By Type

  • Invasive
  • Non-invasive

By Technology

  • Pulmonary Artery Catheter
  • Lithium Dilution Technique
  • Thermodilution Pulse Contour Analysis Technique
  • Arterial Waveform Analysis Technique
  • Doppler
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Top Featured Companies Dominating the Global Cardiac Output Monitoring Devices Market

  • Edwards Lifesciences Corporation
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • ICU Medical, Inc.
  • Baxter International, Inc.
  • Deltex Medical plc
  • CNSystems Medizintechnik GmbH
  • Getinge AB
  • Boston Scientific Corporation (BSC)
  • BioTelemetry, Inc.
  • Masimo Corporation
  • Schwarzer Cardiotek GmbH



Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved